RxDoctor Payments Data

Rachael Pauvlinch, PA

Medical · Cranberry Twp, PANPI 1184137630

Payments from drug & device makers

$9,635in general payments, 2019–2025

Across 607 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$907
  • GSK$885
  • Pfizer$851
  • AstraZeneca$804
  • Lilly USA, LLC$583
  • plus $4K from 45 others

What the payments were for

  • Food & beverage$9,626100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,635 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$24,301
Medicare patients
87
Services billed
585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin54$78,019
EliquisApixaban61$60,924
FarxigaDapagliflozin Propanediol39$41,406
OzempicSemaglutide32$33,887
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$29,049
XareltoRivaroxaban29$24,452
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$22,215
MounjaroTirzepatide20$20,762
JanuviaSitagliptin Phosphate11$13,615
LinzessLinaclotide18$9,110
SynthroidLevothyroxine Sodium104$7,981
VascepaIcosapent Ethyl14$6,836
SynjardyEmpagliflozin/Metformin Hcl11$6,612
Repatha SureclickEvolocumab11$5,602
Levothyroxine Sodium279$3,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy$463$84,63165 claims
PfizerEliquis$851$60,92461 claims
GSKTrelegy Ellipta, Anoro Ellipta$885$51,26462 claims
AstraZenecaFarxiga$804$41,40639 claims
Novo NordiskOzempic$907$33,88732 claims
Johnson & JohnsonXarelto$291$24,45229 claims
Lilly USA, LLCMounjaro$583$20,76220 claims
AbbVieLinzess, Synthroid$1,515$17,090122 claims
MerckJanuvia$281$13,61511 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$56$3,669279 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Cranberry Twp

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →